SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a private debt exchange that effectively converted $1.4 billion of senior notes into equity, a move that the community is actively debating as either a strategic balance sheet cleanup to prepare for potential M&A or as an act of shareholder dilution. Traders are closely monitoring the 35-day volume-weighted average price window for this exchange, while retail sentiment remains deeply polarized between those betting on long-term acquisition catalysts and others expressing frustration over the stock's persistent price stagnation.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee continues to drive intense community conversation around its massive store expansion and solid quarterly revenue growth, fueling persistent speculation about a potential future relisting. Investors are actively debating the company's long-term competitive positioning against rivals, while monitoring the ongoing share repurchase program and its impact on price stability.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investor optimism builds around strong commercial momentum for Briumvi and the expansion into new indications like schizophrenia and myasthenia gravis. The community is actively discussing the potential for a long-term buyout and the ongoing frustration with analyst price targets that lag behind the company's growth trajectory and pipeline development.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is facing significant downward pressure as investors brace for the upcoming quarterly earnings release and the imminent expiration of a major insider lock-up period that threatens to flood the market with millions of shares. While the community is deeply divided between long-term believers citing the company's ambitious space infrastructure goals and bears warning of extreme valuation concerns and potential dilution, the stock remains highly volatile with intense focus on how the market will absorb the looming supply overhang.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is trending as investors digest news of a potential mega-merger with AstraZeneca, a move that would reshape the pharmaceutical landscape and significantly consolidate oncology assets. The community is actively debating the strategic merits of such a deal, specifically focusing on the massive cost-cutting synergies and the necessity of shoring up a pipeline facing significant patent expirations.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is trending following reports that the company has secured a three-year tariff reprieve from the U.S. government by committing to significant domestic manufacturing investments and steep price discounts. Investors and market participants are actively discussing the implications of this major strategic move on the company's long-term margin profile and its competitive standing within the pharmaceutical sector.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

SPRY is trending as investors react to a leadership transition and a challenging commercial environment, with the community actively debating whether the companys recent operational struggles represent a buying opportunity or a deeper failure. Meanwhile, participants are fixated on how these challenges compare to competitors in the needle-free epinephrine space.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Walt Disney Co. is trending as investors weigh strong theatrical box office performance from major intellectual property releases against broader media sector volatility, while the community remains divided over its long-term streaming strategy and the potential impact of corporate restructuring rumors.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solar is trending as investors react to strong quarterly earnings that topped analyst expectations alongside a massive contracted backlog that underscores demand for their domestic manufacturing. The community is actively discussing the stock's breakout potential as it clears major technical hurdles, despite some ongoing volatility and debates regarding sector-wide policy impacts.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is seeing heightened trading volume and sentiment volatility as investors weigh the company's aggressive growth narrative against valuation concerns ahead of the upcoming earnings release. The community remains deeply divided, with bulls pointing to the company's massive contract expansion and AI integration as key catalysts for a rebound, while bears maintain focus on the stock's high valuation multiples and the potential for a sell-the-news reaction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Federated Hermes Q2 Earnings Beat Estimates on Record Managed Assets

FHI beats Q2 earnings estimates as record assets under management and strong revenue growth outweigh higher operating expenses, supporting quarterly results.

Ares Management Q2 Earnings Meet Estimates, AUM Rises Y/Y

ARES' Q2 earnings meet estimates as fee-related earnings and AUM grow y/y, even as revenues missed expectations.

Ares Management Gears Up for Q2 Earnings: Here's What to Expect 

ARES' Q2 results, set to be reported on July 31, are expected to benefit from higher AUM, management fees and revenues, supported by favorable inflows.

Invesco Q2 Earnings Beat Estimates on Higher AUM & Revenues, Stock Up

IVZ's Q2 earnings beat estimates as higher revenues, record inflows and a 23.4% AUM jump outweigh rising expenses.

Top Research Reports for Intel, Dell & Progressive

Intel's AI infrastructure push, Dell's AI server boom and Progressive's premium growth highlight the latest top research reports and key opportunities.

Earnings Estimates Moving Higher for SEI (SEIC): Time to Buy?

SEI Investments (SEIC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

SEI Investments Beats on Q2 Earnings as Revenues & AUM Rise Y/Y

SEIC tops Q2 earnings estimates as revenues, AUM and AUA climb y/y despite higher expenses.

SEI (SEIC) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for SEI (SEIC) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

SEI Investments (SEIC) Q2 Earnings and Revenues Top Estimates

SEI (SEIC) delivered earnings and revenue surprises of +14.48% and +0.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

SEI Reports Second-Quarter 2026 Financial Results

SEI Reports Second-Quarter 2026 Financial Results SEI Reports Second-Quarter 2026 Financial Results PR Newswire OAKS, Pa., July 22, 2026 OAKS, Pa., July 22, 2026 /PRNewswire/ -- SEI Investments Company (NASDAQ: SEIC) today announced financial results for the second quarter 2026. Relative to the...

$SEIC Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $1.63 down -10.44% YoY
• Reported revenue of $641.62M up 14.66% YoY

SEI Investments Co. engages in the provision of investment processing, investment management and investment operations platforms. It operates through the following business segments: Private Banks, Investment Advisors, Institutional Investors, Investment Managers, and Investments in New Businesses. The Private Banks segment provides outsourced investment processing and investment management platforms to banks and trust institutions, independent wealth advisers and financial advisors worldwide. The Investment Advisors segment offers investment management and investment processing platforms to affluent investors through a network of independent registered investment advisors, financial planners and other investment professionals. The Institutional Investors segment delivers investment management and administrative outsourcing platforms to retirement plan sponsors, healthcare systems and not-for-profit organizations worldwide. The Investment Managers segment gives investment operations outsourcing platforms to fund companies, banking institutions and both traditional and non-traditional investment managers worldwide. The Investments in New Businesses segment focuses on the provision of investment management programs to ultra-high-net-worth families residing in the United States, developing internet-based investment services and advice platforms, entering new markets and conducting other research and development activities. The company was founded by Alfred P. West, Jr. in 1968 and is headquartered in Oaks, PA.

SEI Investments Co.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

SEICSEI Investments Co.

Fundamentals

Connect Stocktwits to ChatGPT

Latest SEIC News